• Register
  • Login
  • Subscribe
  • Contact Us

Purchase and Successive Delivery of the Aflibercept Medicinal Product.

PolandTenders notice for Purchase and Successive Delivery of the Aflibercept Medicinal Product.. The reference ID of the tender is 123908361 and it is closing on 22 Aug 2025.

Tender Details

  • Country: Poland
  • Summary: Purchase and Successive Delivery of the Aflibercept Medicinal Product.
  • PLT Ref No: 123908361
  • Deadline: 22 Aug 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 2025/BZP 00359319/01
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • 1 For the needs of the University Clinical Hospital Fryderyk Chopin in Rzeszow. 2. A detailed description of the subject of the skew, the requirements of the Ordering Party were specified in the price and offer form (ZEKIK No. 1 to SWZ) will be integrated in honor of SWZ. 3. The Ordering Party requires the subject of the sort of pollination, which: 3.1. SUFFICIENTS SUPPORTS described in the price -offer form; 3.2. SUFFICATIONS SUPPLY described in SWZ; 3.3. is the laws of May 12, 2011 on the reimbursement of LEKW, Special Purpose Education Rodkw of life and medical devices (Journal of Laws of 2025 item 907). 4. The scope of the fall includes the successive supply of the subject of the subject of the poll in the balanced quantity in the price -offer form (including No. 1 to SWZ) for 12 months from the date of the contract; 5. Deadline for the execution: 5.1 Purchase and successive delivery of the subject of the pollination for 12 months from the date of the contract. 5.2 of the Ordering Party allows the Channel to amend the deadline for the contract concluded with the contractors in the event of failure to implement during its duration of the subject of the contract. In such Estates ...
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Purchase and Successive Delivery of the Aflibercept Medicinal Product. - Poland Tender

The UNIVERSITY CLINICAL HOSPITAL FRYDERYK CHOPIN IN RZESZOW, a Government sector organization in Poland, has announced a new tender for Purchase and Successive Delivery of the Aflibercept Medicinal Product.. This tender is published on PolandTenders under PLT Ref No: 123908361 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-22.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

PolandTenders Features

PolandTenders Features

Fresh and verified Tenders from Poland. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting PolandTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Poland in your email inbox.

  Chat with us